Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Breast Neoplasms 70Neoplasm Metastasis 11Prostatic Neoplasms 9Pain 8Osteoporosis 8Multiple Myeloma 5Humoral Hypercalcemia Of Malignancy 4Triple Negative Breast Neoplasms 3Bone Diseases, Metabolic 3Neoplasms 2Lung Neoplasms 2Breast Neoplasms, Male 2Bone Neoplasms 2Bone Diseases 2Renal Insufficiency 1Ovarian Neoplasms 1Neovascularization, Pathologic 1Neoplastic Cells, Circulating 1Neoplasms by Site 1Neoplasm Micrometastasis 1Metastatic Breast Cancer With Bone Involvement 1Hereditary Breast and Ovarian Cancer Syndrome 1Fractures, Bone 1Fatigue 1Carcinoma, Non-Small-Cell Lung 1Carcinoma, Intraductal, Noninfiltrating 1Carcinoma, Ductal, Breast 1Breast Diseases 1Breast Cancer Metastatic 1

Interventions

Fulvestrant 6Letrozole 4Capecitabine 4exemestane 3dalpiciclib 3Trastuzumab 3Docetaxel 3Anastrozole 3ribociclib 2palbociclib 2fluzoparib 2apatinib 2Irinotecan 2Gemcitabine 2tusamitamab ravtansine 1trastuzumab deruxtecan 1sacituzumab govitecan 1pyrotinib 1pegfilgrastim 1patritumab deruxtecan 1olaparib 1nirogacestat 1margetuximab 1irinotecan sucrosofate 1abemaciclib 1Zoledronic Acid 1Vinorelbine 1Tamoxifen 1Rogaratinib 1Patient Reported Outcome Measures 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Breast Cancer Metastatic × Zoledronic Acid × Breast × Clear all
NCT06876636 2025-07-29

Zoledronic Acid Combined With EC-T for Triple-Negative Breast Cancer

Xijing Hospital

Phase NA Active not recruiting
99 enrolled
Breast

Breast Cancer Metastatic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡